Abstract:Paradoxically, aggregation of specific proteins is characteristic of many human diseases and aging, yet aggregates have increasingly been found to be unnecessary for initiating pathogenesis. Here we determined the NMR topology and dynamics of a helical mutant in a membrane environment transformed from the 125-residue cytosolic all-β MSP domain of vesicle-associated membrane protein-associated protein B (VAPB) by the ALS-causing P56S mutation. Despite its low hydrophobicity, the P56S major sperm protein (MSP) domain becomes largely embedded in the membrane environment with high backbone rigidity. Furthermore it is composed of five helices with amphiphilicity comparable to those of the partly-soluble membrane toxin mellitin and α-synuclein causing Parkinson's disease. Consequently, the mechanism underlying this chameleon transformation becomes clear: by disrupting the specific tertiary interaction network stabilizing the native all-β MSP fold to release previously-locked amphiphilic segments, the P56S mutation acts to convert the classic MSP fold into a membrane-active protein that is fundamentally indistinguishable from mellitin and α-synuclein which are disordered in aqueous solution but spontaneously partition into membrane interfaces driven by hydrogen-bond energetics gained from forming α-helix in the membrane environments. As segments with high amphiphilicity exist in all proteins, our study successfully resolves the paradox by deciphering that the proteins with a higher tendency to aggregate have a stronger potential to partition into membranes through the same mechanism as α-synuclein to initially attack membranes to trigger pathogenesis without needing aggregates. This might represent the common first step for various kinds of aggregated proteins to trigger familiar, sporadic and aging diseases. Therefore the homeostasis of aggregated proteins in vivo is the central factor responsible for a variety of human diseases including aging. The number and degree of the membrane attacks by aggregated proteins may act as an endogenous clock to count down the aging process. Consequently, a key approach to fight against them is to develop strategies and agents to maintain or even enhance the functions of the degradation machineries.

N-glycosylation as a eukaryotic protective mechanism against protein aggregation

Proteins in Aggregates Functionally Impact Multiple Neurodegenerative Disease Models by Forming Proteasome-Blocking Complexes

N-Glycosylation as a Modulator of Protein Conformation and Assembly in Disease

Understanding the Role of Protein Glycation in the Amyloid Aggregation Process

Glycosylation Significantly Inhibits the Aggregation of Human Prion Protein and Decreases Its Cytotoxicity

Molecular Stressors Engender Protein Connectivity Dysfunction through Aberrant N-Glycosylation of a Chaperone

Emerging roles of O-glycosylation in regulating protein aggregation, phase separation, and functions

Vertebrate protein glycosylation: diversity, synthesis and function

Modulation of amyloid assembly by glycosaminoglycans: from mechanism to biological significance

Post-translational Modification of α-Synuclein Modifies Monomer Dynamics and Aggregation Kinetics

Protein Aggregation: Opposing Effects of Chaperones and Crowding

Molecular insights into aggrephagy: Their cellular functions in the context of neurodegenerative diseases

O-Glycosylation Induces Amyloid-β To Form New Fibril Polymorphs Vulnerable for Degradation

Resolving the paradox for protein aggregation diseases: NMR structure and dynamics of the membrane-embedded P56S-MSP causing ALS imply a common mechanism for aggregation-prone proteins to attack membranes

Post-translational modifications: Regulators of neurodegenerative proteinopathies

O-GlcNAcylation Inhibits the Oligomerization of Alpha-Synuclein by Declining Intermolecular Hydrogen Bonds Through a Steric Effect.

Anti-aggregate activity

N‐Glycosylation‐induced pathologic protein conformations as a tool to guide the selection of biologically active small molecules

Regulated N-glycosylation controls chaperone function and receptor trafficking

A safety mechanism enables tissue-specific resistance to protein aggregation during aging in C. elegans

Differential effects of putative N-glycosylation sites in human Tau on Alzheimer’s disease-related neurodegeneration